Humana 2006 Annual Report Download - page 29

Download and view the complete annual report

Please find page 29 of the 2006 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 126

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126

Failure to adequately price our products or estimate sufficient medical claim reserves may result in a
material adverse effect on our financial position, results of operations and cash flows.
If we do not design and price our products properly and competitively, our membership and profitability
could decline.
We are in a highly competitive industry. Some of our competitors are more established in the health care
industry in terms of a larger market share and have greater financial resources than we do in some markets. In
addition, other companies may enter our markets in the future, including emerging competitors in the Medicare
program and in consumer-choice health plans, such as high deductible health plans with HSAs. We believe that
barriers to entry in many markets are not substantial, so the addition of new competitors can occur relatively
easily, and customers enjoy significant flexibility in moving between competitors. Contracts for the sale of
commercial products are generally bid upon or renewed annually. While health plans compete on the basis of
many factors, including service and the quality and depth of provider networks, we expect that price will
continue to be a significant basis of competition. In addition to the challenge of controlling health care costs, we
face intense competitive pressure to contain premium prices. Factors such as business consolidations, strategic
alliances, legislative reform and marketing practices create pressure to contain premium price increases, despite
being faced with increasing medical costs. The commercial pricing environment, particularly in the 2 to 300
member groups, is extremely competitive. We believe some of our competitors, including public and
not-for-profit companies, are pricing aggressively to gain market share.
Premium increases, introduction of new product designs, and our relationship with our providers in various
markets, among other issues, could also affect our membership levels. Other actions that could affect
membership levels include our possible exit from or entrance into Medicare or Commercial markets, or the
termination of a large contract, including our TRICARE contract.
If we do not compete effectively in our markets, if we set rates too high or too low in highly competitive
markets to keep or increase our market share, if membership does not increase as we expect, if membership
declines, or if we lose accounts with favorable medical cost experience while retaining or increasing membership
in accounts with unfavorable medical cost experience, our business and results of operations could be materially
adversely affected.
If we fail to effectively implement our operational and strategic initiatives, including our Medicare
initiatives, our business could be materially adversely affected.
Our future performance depends in large part upon our management team’s ability to execute our strategy to
position the Company for the future. This strategy includes opportunities created by the MMA. The MMA offers
new opportunities in our Medicare programs, including our HMO, PPO, and PFFS Medicare Advantage
products, as well as our stand-alone PDP products. We have made substantial additional investments in the
Medicare program to enhance our ability to participate in these expanded programs. Over the last few years we
have increased the size of our Medicare geographic reach since the enactment of the MMA through expanded
Medicare product offerings. We are offering both the stand-alone Medicare Prescription Drug Coverage and
Medicare Advantage Health Plan with Prescription Drug Coverage in addition to our other product offerings. We
have been approved to offer the Medicare prescription drug plan in 50 states as well as Puerto Rico and the
District of Columbia. The growth in our Medicare membership and revenues impacts the pattern of our quarterly
earnings, including the timing of membership enrollment and the speed with which the individual members meet
their deductibles and cost-sharing provisions.
We have also made substantial investments in the service personnel and technology necessary to administer
the growing Medicare business. We continue to work with CMS to devise solutions to certain CMS systems
issues that have created some difficulty receiving correct information about eligibility of certain low income
persons in the Part D program.
17